VCP p.Arg191Gln mutation in a patient with semantic dementia: a case report

Ryota Kobayashi1, Hiroya Naruse2, Akihito Suzuki1

  • 1Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan.

Neurocase
|July 23, 2025
PubMed

Insights

Valosin-containing protein (VCP) gene variants can cause frontotemporal lobar degeneration (FTLD). This study identifies a new VCP variant, p.Arg191Gln, associated with semantic dementia (SD), expanding the known FTLD spectrum.

Area of Science:

  • Neurogenetics
  • Neurology
  • Molecular Biology

Background:

  • Valosin-containing protein (VCP) gene variants are linked to inclusion body myopathy, Paget's disease of bone, and frontotemporal dementia (FTD).
  • Pathogenic VCP variants typically manifest as behavioral-variant FTD (bvFTD) or, rarely, semantic dementia (SD).
  • The VCP p.Arg155Cys variant is the only previously reported VCP mutation associated with SD.

Purpose of the Study:

  • To report a novel case of semantic dementia (SD) caused by a pathogenic VCP variant.
  • To investigate the phenotypic spectrum of VCP-related frontotemporal lobar degeneration (FTLD).

Main Methods:

  • Case report of a Japanese female patient diagnosed with SD.
  • Genetic analysis including whole-exome and Sanger sequencing to identify VCP variants.
  • Clinical evaluation for neurological and systemic symptoms.

Main Results:

  • A female patient presented with SD at age 56, characterized by language and behavioral changes.
  • Genetic analysis revealed the novel pathogenic VCP variant p.Arg191Gln in the patient.
  • The patient exhibited isolated SD without myopathy, pyramidal signs, or bone disease, progressing to severe disability and death.

Conclusions:

  • The VCP p.Arg191Gln variant can cause isolated semantic dementia (SD).
  • This case expands the known spectrum of frontotemporal lobar degeneration (FTLD) phenotypes associated with pathogenic VCP variants.
  • VCP-related disorders encompass a broader range of FTLD presentations than previously recognized.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
Visual Agnosia01:12

Visual Agnosia

Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
307
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
90
Prosopagnosia01:24

Prosopagnosia

Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
258
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
713